SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Gorevic Jason N – ‘5’ for 12/31/19 re: Teladoc Health, Inc.

On:  Wednesday, 2/12/20, at 4:25pm ET   ·   For:  12/31/19   ·   Accession #:  1179110-20-1513   ·   File #:  1-37477

Previous ‘5’:  ‘5’ on 1/16/18 for 12/31/17   ·   Next & Latest:  ‘5’ on 2/10/21 for 12/31/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/12/20  Gorevic Jason N                   5                      1:5K   Teladoc Health, Inc.              Section16 Direct/FA

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 5   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 5           Annual Statement of Changes in Beneficial           HTML      3K 
                Ownership of Securities by an Insider --                         
                edgar.xml/3.6                                                    




        

This ‘5’ Document is an XML Data File that may be rendered in various formats:

  Form 5    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
XML Data rendering:  Annual Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0306 </schemaVersion>
<documentType> 5 </documentType>
<periodOfReport> 2019-12-31 </periodOfReport>
<notSubjectToSection16> 0 </notSubjectToSection16>
<form3HoldingsReported> 0 </form3HoldingsReported>
<form4TransactionsReported> 0 </form4TransactionsReported>
<issuer>
<issuerCik> 0001477449 </issuerCik>
<issuerName> Teladoc Health, Inc. </issuerName>
<issuerTradingSymbol> TDOC </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001208500 </rptOwnerCik>
<rptOwnerName> GOREVIC JASON N </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O TELADOC HEALTH, INC., </rptOwnerStreet1>
<rptOwnerStreet2> 2 MANHATTANVILLE ROAD, SUITE 203 </rptOwnerStreet2>
<rptOwnerCity> PURCHASE </rptOwnerCity>
<rptOwnerState> NY </rptOwnerState>
<rptOwnerZipCode> 10577 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 1 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> Chief Executive Officer </officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2019-03-12 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 5 </transactionFormType>
<transactionCode> G </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 341 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0.00 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> D </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 641924 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeTransaction>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2019-12-26 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 5 </transactionFormType>
<transactionCode> G </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 2000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0.00 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> D </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 641924 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<derivativeTable></derivativeTable>
<footnotes></footnotes>
<ownerSignature>
<signatureName> /s/ Adam C. Vandervoort, attorney-in-fact </signatureName>
<signatureDate> 2020-02-12 </signatureDate>
</ownerSignature>
</ownershipDocument>


Top
Filing Submission 0001179110-20-001513   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 7:32:34.1pm ET